Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Shanghai Stock Exchange 600329.SS

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Operating Income Margin for the year ending December 31, 2023: 13.34%

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Operating Income Margin is 13.34% for the year ending December 31, 2023, a 12.30% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Operating Income Margin for the year ending December 31, 2022 was 11.88%, a -5.31% change year over year.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Operating Income Margin for the year ending December 31, 2021 was 12.55%, a 5.52% change year over year.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Operating Income Margin for the year ending December 31, 2020 was 11.89%, a 9.56% change year over year.
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Operating Income Margin for the year ending December 31, 2019 was 10.85%, a 7.56% change year over year.

Key data

Date	Operating Income Margin	EBT Margin	Net Income Margin	EBITDA Margin

Shanghai Stock Exchange: 600329.SS

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

CEO	Mr. Jian Ma
IPO Date	June 6, 2001
Location	China
Headquarters	Zhong Xin Mansion
Employees	4,619
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Consumer Packaged Goods Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care Tobacco

Description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Key trends

Past 5 years